David Sinclair on the Longevity Pill, Age Reversal Timelines, and Updated Protocols | EP #249

Sinclair has taken resveratrol for over 15 years, calling it a staple. He mentions that the sirtuins, which he has worked on for decades, are now being shown to play a critical role in the information theory of aging and the reprogramming system that can literally reset cell age. He says they have 'really good data' being submitted to Nature. He also notes that his father, 86 and in perfect health, follows the same regimen. The key insight is that bioavailability is low without a carrier fat; he suggests mixing with olive oil or yogurt.

Sinclair places strong emphasis on glucose control, citing Peter’s Fountain Life data that hemoglobin A1c is the top correlate of heart disease, not cholesterol. He advocates looking at glucose, pasta, and processed carbs. He and Serena have taken metformin for years but cycle it with berberine to avoid side effects and perhaps maintain efficacy. He notes that a natural option like berberine can be used by those who don't want a prescription or have GI issues.

He describes that nattokinase comes from natto, a Japanese breakfast food. He hates the taste, so he takes pills. Clinical trials used at least 8,000 or 10,000 units, and 6,000 units didn't show benefit; it took a year for plaque reversal. He is conducting a personal experiment: he will have a carotid ultrasound to see if his intima-media thickness has improved. He also cautions against CT scans due to radiation, preferring ultrasound for tracking.

He credits Serena entirely for this switch. She confronted his nightly cheese and red wine habit, and he switched to a plant-based diet. Within a month, his inflammation markers plummeted, convincing him to stick with it. This change dovetails with his earlier advocacy for the Mediterranean diet but now he avoids dairy and alcohol.

He shares that before meeting Serena, he lived on edge, ruminating about not being good enough. She introduced meditation and the mindset of chilling, which improved his sleep, appearance, and overall well-being. He emphasizes that loneliness kills and that having a partner, pet, or community is a longevity intervention as important as drugs. He also advocates hugs. He now feels better and looks better.

He references his lab's finding that radiation accelerates aging, so he prefers to avoid CT. His Fountain Life trips include carotid ultrasound. He is currently using it to monitor the effect of nattokinase on his own carotid plaque.

He explains that before meeting Serena, he was a daily drinker. Serena insisted he stop, citing emerging evidence that even one glass of alcohol daily correlates with a smaller brain. He reluctantly gave it up and within a month saw a significant drop in inflammatory biomarkers. He now only drinks alcohol on rare celebratory occasions, acknowledging that daily consumption is detrimental for longevity.

He tells the story of Serena telling him to stop eating cheese and red wine and try a plant-based approach. Initially skeptical, he complied and within a month saw inflammation plummet. He now eats mostly vegan, though still occasionally enjoys Japanese sushi. He credits Serena entirely for this change.

He describes being a driven Type A individual who was never satisfied unless he was number one. That constant stress and rumination accelerated his aging. After meeting Serena, she taught him to breathe and chill, and he's been working on meditation. He notes that chronic tension is proven to accelerate aging, and that loneliness, blood pressure, and cholesterol also matter. He now sleeps better, looks and feels better.

He draws the Wright brothers analogy: just as flight seemed impossible until it happened, age reversal will transform everything. He states that once we can fly, everything changes, and he believes that in 2026 we will know if we can 'fly' in longevity. He adds that even if his trial hits a snag, the broader field has multiple efforts, so the proof is coming soon.

He explains that getting a CT scan for cardiovascular screening involves radiation, which in his lab's research accelerates aging. Instead, he uses a 20-minute carotid ultrasound to measure intima-media thickness (IMT), which is safer. He is currently doing an n-of-1 experiment to see if nattokinase reduces his IMT, so he'll have a follow-up ultrasound.

He describes how the traditional grant system is backwards, time-consuming, and biased toward safe, predictable projects. When his funding was cut, he was glum. Within months, the Friends of Sinclair Lab brought in over $6 million annually, freeing him from grant writing and allowing instant responses to ideas. He gives an example: when a member offered to fund a kidney regeneration project for a student in renal failure, they started within weeks. He views this model as vastly superior and plans to teach other scientists.

He explains that while the AAV gene therapy is going into human eyes, his lab has been working on a cheaper alternative since 2017—small molecules identified via in silico AI screening of billions of molecules. They now have a three-molecule cocktail that, like the gene therapy, can reprogram skin cells from 92-year-olds back to a youthful state. They plan to enter a clinical trial in months as part of the Healthspan X-Prize. He aims to reduce the cocktail to a single molecule for FDA approval. The ambition is to make a pill that costs pennies per dose, like metformin.